Purpose Treatment recommendations for localized paratesticular rhabdomyosarcoma (PT
RMS) differ in North America and Europe. We conducted a pooled analysis to identify …

BACKGROUND Paratesticular rhabdomyosarcoma (PTRMS) is the most common primary
solid tumor arising from the mesenchymal tissue of the testis. Traditionally, retroperitoneal …

PURPOSE: We report the experience of the German-Italian Cooperative Group with 216
pediatric patients with paratesticular rhabdomyosarcoma treated over 20 years. PATIENTS …

Paratesticular rhabdomyosarcoma (PT‐RMS) carries a favorable prognosis, but questions
persist regarding optimal management. Our goal was to determine the importance of primary …

Objective: To evaluate outcome in respect to local treatment strategies in 4 prospective CWS
trials in patients with paratesticular rhabdomyosarcoma (PTRMS). Summary Background …

Abstract Background Paratesticular rhabdomyosarcoma (PT RMS) is rare compared to
benign scrotal pathology. Inappropriate first surgery (InFS) required supplementary …

Methods: After primary surgical excision, 7 patients were classified into group I according to
the Intergroup Rhabdomyosarcoma Study Group (IRSG) Postsurgical Grouping …

To determine patient and tumor characteristics that could predict pathologic findings after
retroperitoneal lymph node dissection (RPLND) in paratesticular rhabdomyosarcoma …

Background Staging retroperitoneal lymph node dissection (RPLND) for paratesticular
rhabdomyosarcoma (RMS) is recommended for all patients aged≥ 10 y. The purpose of this …

Purpose To report the results from International Society of Pediatric Oncology (SIOP)
Malignant Mesenchymal Tumors studies (MMT 89 and 95) of males with nonmetastatic …